NCT02306161

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2014-12-12Est. Completion: 2021-03-31

Enrollment target: 312 participants

Locations

Children's Hospital of Alabama, Birmingham, Alabama, United States
USA Health Strada Patient Care Center, Mobile, Alabama, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
Banner Children's at Desert, Mesa, Arizona, United States
Phoenix Childrens Hospital, Phoenix, Arizona, United States
Banner University Medical Center - Tucson, Tucson, Arizona, United States
Onvida Health Yuma Medical Center, Yuma, Arizona, United States
CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Kaiser Permanente Downey Medical Center, Downey, California, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
Loma Linda University Medical Center, Loma Linda, California, United States
Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States
Children's Hospital Los Angeles, Los Angeles, California, United States
Valley Children's Hospital, Madera, California, United States

Sarcoma, EwingNeoplasm Metastasis

The purpose of this study is to measure the benefit of adding abemaciclib to chemotherapy (irinotecan and temozolomide) …

Phoenix, United StatesEst. completion Jan 15, 2025

Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaBone SarcomaTranslocation-associated Soft Tissue SarcomaSynovial SarcomasOsteosarcoma Metastatic

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.